147 related articles for article (PubMed ID: 4154960)
21. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
[TBL] [Abstract][Full Text] [Related]
22. Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond.
Nasrallah HA
J Clin Psychiatry; 2007; 68 Suppl 1():3-4. PubMed ID: 17286521
[No Abstract] [Full Text] [Related]
23. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
Donlon PT; Rada RT
Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
[TBL] [Abstract][Full Text] [Related]
24. A preliminary approach to the problems of relating the pharmacokinetics of phenothiazines to clinical response with schizophrenic patients [proceedings].
Gottschalk LA
Psychopharmacol Bull; 1978 Jul; 14(3):35-9. PubMed ID: 27839
[No Abstract] [Full Text] [Related]
25. [Medical procedure with aggressive patients: experiences of psychiatric clinic in Wroclaw].
Kiejna A; Jańska-Skomorowska M; Baranowski P
Psychiatr Pol; 1993; 27(5):501-13. PubMed ID: 7902991
[TBL] [Abstract][Full Text] [Related]
26. Clinical experience with piperacetazine in hospitalized mental patients. A four year study.
Ralston JD; Abreu BE
J Indiana State Med Assoc; 1970 Nov; 63(11):1291-6. PubMed ID: 5495472
[No Abstract] [Full Text] [Related]
27. [Pilot study on oxaflumazine, a new piperazinated phenothiazine].
Villeneuve A; Dogan K; Lachance R; Drolet A
Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378
[No Abstract] [Full Text] [Related]
28. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients.
Gallant DM; Bishop MP
Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346
[No Abstract] [Full Text] [Related]
29. Kraepelinian subtype and deficit syndrome in chronic schizophrenia.
Nakaya M; Ohmori K
Psychiatry Res; 2006 Nov; 144(2-3):221-5. PubMed ID: 16962177
[TBL] [Abstract][Full Text] [Related]
30. [Indications for the use of neuleptil. Review of the literature and clinical contribution].
Catalano A; Del Pistoia L; De Risio C; Ridolo P
Riv Sper Freniatr Med Leg Alien Ment; 1967; 91():Suppl 5:1307+. PubMed ID: 4388059
[No Abstract] [Full Text] [Related]
31. Drug responses of three hospital population samples participating in a collaborative study.
Crane GE; Krummholz W; Lichtigfeldt FJ; Salim T
Arzneimittelforschung; 1966 Feb; 16(2):290-3. PubMed ID: 4383294
[No Abstract] [Full Text] [Related]
32. [Use of the new neuroleptic drug leptril in psychiatric practice].
Gurovich IIa; Averbakh IaK; Niss AI; Afanas'ev IuI; Novik EI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(3):443-6. PubMed ID: 4147493
[No Abstract] [Full Text] [Related]
33. [Comparative study of the activity of 2 neuroleptics].
Blanc M; Borenstein P; Brion S; Buisson JF; Debray HR; Digo R; Flavigny H; Follin S; Minvielle J; Morel-Maroger A; Pichot P; Rainaut J; Sutter JM
Encephale; 1970; 59(2):97-161. PubMed ID: 5458713
[No Abstract] [Full Text] [Related]
34. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
Vinci M
Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
[No Abstract] [Full Text] [Related]
35. A comparison of mesoridazine and chlorpromazine in chronic psychiatric patients.
Douglas KW; Hindley JP
J Clin Pharmacol J New Drugs; 1969; 9(3):176-82. PubMed ID: 4892453
[No Abstract] [Full Text] [Related]
36. A clinical study with propericiazine in chronic psychotic patients.
Deutsch M; Ananth JV; Ban TA
Curr Ther Res Clin Exp; 1971 Jun; 13(6):353-8. PubMed ID: 4397391
[No Abstract] [Full Text] [Related]
37. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
[TBL] [Abstract][Full Text] [Related]
38. [Tolerance of bromperidol in long term application].
Scelovic B
Int Pharmacopsychiatry; 1978; 13 Suppl 1():38-40. PubMed ID: 35477
[No Abstract] [Full Text] [Related]
39. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
[No Abstract] [Full Text] [Related]
40. [Experience with long acting psychopharmaceutics in psychiatric hospitals].
Reimer F
Int Pharmacopsychiatry; 1974; 9(4):245-7. PubMed ID: 4156352
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
